Status Unknown

Phase Not Applicable
Age: 18Years - 70Years
All Genders
ID04352153

A Randomized, Prospective, Controlled Study of the Efficacy and Safety of Uralyt-U Combined With Febuxostat in the Treatment of Hyperuricemia With Uric Acid Stones

Led by Ai Peng · Updated on 2020-04-20

102

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of the study is to provide a more direct and objective basis for the widespread use of potassium sodium hydrogen citrate granules in the treatment of uric acid stones.

CONDITIONS

Brief Title

Role of Uralyt-U in Patients With Hyperuricemia

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18-70 years old, male, outpatient or inpatient;
  • Acidic urinary stones
  • Serum uric acid value ≥480 µmol / L;
  • Other concomitant diseases (such as hypertension, hyperlipidemia, diabetes, etc.) are in a stable condition, and the dosage of other diseases is not changed during the test.
  • eGFR≥30ml / min;
Not Eligible

You will not qualify if you...

  • Pregnant or lactating women;
  • Patients with acute or chronic renal failure (eGFR <30ml / min);
  • Patients with severe liver dysfunction (ALT, AST≥70 IU);
  • In patients with uncontrolled hypertension, systolic blood pressure ≥160 and / or diastolic blood pressure ≥110mmHg;
  • In uncontrolled diabetic patients, fasting blood glucose is> 10mmol / L, and / or glycated hemoglobin is ≥9%;
  • Patients that are taking atorvastatin, losartan, amlodipine, fenofibrate, pyrazinamide, tincture diuretics, thiazide diuretics, glucocorticoids, immunosuppressive agents and other drugs that affect uric acid excretion Drugs, those taking aspirin at a dose of> 325mg / day;
  • Cancer patients

Trial Site Locations

Total: 1 location

1

Department of Nephrolgoy, Shanghai 10th People's Hospital

Shanghai, Shanghai Municipality, China, 200072

Actively Recruiting

Loading map...

Research Team

A

Ai Peng, Ph.D., M.D.

J

Jiafen Cheng, M.D.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Dose Escalation Study of IG3018 to Evaluate the Safety, To...

Hyperuricemia

Actively Recruiting

6 locations

A Phase 1, Double-blinded, Placebo-controlled Study of Singl...

Healthy Volunteers

Actively Recruiting

2 locations

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Comparison potassium sodium hydrogen citrate with sodium bicarbonate in urine alkalization: a prospective crossover-controlled trial.

Wen Xue, Jiafen Cheng, Jing Zhao...

https://pubmed.ncbi.nlm.nih.gov/36261757